Hazard Information | Back Directory | [Uses]
Ralpancizumab is a selective PCSK9 inhibitor with potential application in hemorrhagic stroke[1]. | [References]
[1] Sanz-Cuesta BE, et al. Lipid-Lowering Therapy and Hemorrhagic Stroke Risk: Comparative Meta-Analysis of Statins and PCSK9 Inhibitors. Stroke. 2021 Oct;52(10):3142-3150. DOI:10.1161/STROKEAHA.121.034576 |
|
Company Name: |
Biolab Reagents
|
Tel: |
18108604356 18108604356 |
Website: |
www.biolabreagent.com/ |
Company Name: |
Cell Sciences
|
Tel: |
9785721070 |
Website: |
www.cellsciences.com |
|